Hunan Warrant Pharmaceutical688799.SHValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 19, 2026, Hunan Warrant Pharmaceutical (688799.SH) trades at a P/E of 27.90x, P/B of 3.04x, P/S of 4.88x, and a dividend yield of 0.37%.
Longitudinal percentile comparison: P/E sits at the 77th percentile over the trailing 10Y window (vs. 62nd percentile over 3Y); P/B sits at the 75th percentile over the trailing 10Y window (vs. 64th percentile over 3Y); P/S sits at the 87th percentile over the trailing 10Y window (vs. 78th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 37th percentile within its industry and the 39th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.37%, ranking at the 17th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 1.7 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Hunan Warrant Pharmaceutical operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHA: 688799 · SSE: 688799 · 688799
Want the full picture on whether Hunan Warrant Pharmaceutical (688799.SH) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 27.90 | ||||||
| P/B (MRQ) | 3.04 | ||||||
| P/S (TTM) | 4.88 | ||||||
| Dividend Yield | 0.37% | ||||||
| Buyback + Div Yield | 0.37% |